Quest Diagnostics (DGX) came out with quarterly earnings of 2.35pershare,beatingtheZacksConsensusEstimateof2.31 per share. This compares to earnings of 2.30pershareayearago.Thesefiguresareadjustedfornon−recurringitems.QuestDiagnostics,whichbelongstotheZacksMedical−OutpatientandHomeHealthcareindustry,postedrevenuesof2.4 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.50%. This compares to year-ago revenues of $2.34 billion. The ...